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Key questions
What is already known about this subject?
 ► Use of social media is ubiquitous and becoming 
an integral part of how people communicate and 
learn. These diverse platforms have inevitably joined 
the forefront of young cancer patients’ ecosystem 
for coping with cancer in daily life, whether to find 
health information or as a safe place for support and 
solace. Multiple studies have surveyed online popu-
lations to identify how patients use these platforms, 
others have used them to identify cohorts for rare 
diseases. In general, these studies identify specific 
subgroups of patients. Studies on social media are 
burgeoning in other fields as well, such as in psychi-
atry where they have shown to reduce patient anx-
iety, and infectious diseases, as a means to survey 
health and detect disease outbreaks.
What does this study add?
 ► Herein, we present data from a major digital social 
network, which is accessible to the breadth of young 
patients with cancer, regardless of cancer type and 
stage. We collected information on demographics 
and usage traits in order to characterise user profile 
of these platforms. We found no differences in plat-
form usage between patients with active and non- 
active disease, suggesting a challenge in transition 
to survivorship. This issue can be addressed by de-
veloping designated activities geared towards aid-
ing survivors reintegrate into the workforce, or with 
targeted online support groups. Social networks 
represent a mean for learning our young patients’ 
environment, patient education via interference 
through the platform and also a research tool.
How might this impact on clinical practice?
 ► Physicians should be aware of the rapidly changing 
landscape of a patient’s experience and find the ap-
propriate way to join the discussion beyond office 
walls. It has the potential to improve communication 
with patients and the support system around them, 
to ensure that adequate and accurate information is 
delivered online, to collect data quickly and efficient-
ly, and ultimately, to enhance patient care.
AbstrAct
Introduction Digital social networks have become a key 
player in the ecosystem of young patients with cancer, with 
regard to their unique perspectives and unmet needs. This 
study aims to investigate the web- based social community 
tools and to characterise the user profile, unmet needs and 
goals of young patients with cancer.
Methods A web- based survey was distributed via large- 
scale social network designated for young patients with 
cancer (age 18–45 years) Stop Cancer. The survey collected 
demographic data and oncological status. Primary outcome 
was potential goals of accessing the network; secondary 
outcomes were emotional impact, effect of disease 
status, education, marital status and employment, on user 
satisfaction rate.
Results The survey was available for 5 days (10/2018) and 
was filled by 523 participants. Breast cancer, haematological 
malignancies and colorectal cancer were the most common 
diagnoses. The majority had non- metastatic disease at 
diagnosis, 79% had no evidence of disease at time of the 
survey. Forty- five per cent considered the network as a 
reliable source for medical information. Academic education 
was associated with higher satisfaction from the platform. 
There were no differences between cancer survivors and 
patients with active disease in patterns of platform usage. 
The social network had an allocated section for ‘patient 
mentoring’ of newly diagnosed members by survivors.
Discussion Our study portrayed the user prototype of a 
social digital network among young adult patients with 
cancer, indicating challenging trends. Whereas social media 
may prove a powerful tool for patients and physicians 
alike, it may also serve as a research tool to appraise wide 
practices within a heterogeneous population. Nevertheless, it 
acts as a double- edged sword in the setting of uncontrolled 
medical information. It is our role as healthcare providers to 
join this race and play an active role in shaping its medical 
perspectives.
IntRoDuCtIon
The role of digital social networks among 
young patients with cancer has evolved in 
the biosphere of their unique perspectives 
and unmet needs. As digital natives, they 
exploit cancer- related social networks ever 
more frequently, leading to an emerging 
reality parallel to traditional medical care.1 A 
burgeoning variety of online resources exists 
today: forums, blogs, tweet chats, message 
boards and organisational websites2 Addition-
ally, cellphone apps like Belong help patients 
stay connected. Young population turn to 
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Figure 1 Demographic characteristics of stop cancer digital network users. GU, Genitourinary; RT, Radiotherapy; NED, No 
Evidence of Disease.
social media for health information and answers to age- 
specific issues in reintegrating in normal life. They also 
use it to find support and reduce anxiety.3 They place 
social media as a top helpful resource along with support 
from family and friends in a recent comprehensive Delphi 
panel; moreover, they most often use these resources to 
reduce feelings of loneliness, create a sense of belonging 
and as a platform for meeting others like them.2 It had 
been previously reported that the major digital social 
platforms, representing the web- based social ‘commu-
nity’ tools,4 had become a potential game changer in 
cancer care with the potential for wide scale effects. In 
our previous publication in The Lancet Oncology, we 
described the use of social media in oncology.4 We used 
the online portal, Stop Cancer and studied a wide variety 
of young cancer patients. In only 1 week, we had gath-
ered over 500 patients between the ages 20–45. In this 
following article, we show the user profile, unmet needs 
and goals of young cancer patients as a means to study the 
clinical and emotional landscape that exists in parallel to 
the traditional healthcare and support setting.
MetHoDs
A web- based survey was distributed via the large- scale social 
network designated for young patients ith cancer (aged 
18–45 years) Stop Cancer to all users. The survey collected 
demographic data from the variety of cancer patients 
such as age, sex, living arrangement, academic education, 
employment, religion and oncological status, such as meta-
static or non- metastatic cancer, and the treatment they 
received. Primary outcome was potential goals of accessing 
the network; secondary outcomes were emotional impact, 
and effect of disease status, education, marital status and 
employment on satisfaction from using the platform. 
Patients were asked to rate the adequacy of statements: 
‘using the platform alleviated my sense of seclusion’ and 
‘using the platform induced anxiety’. All outcomes reported 
herein were considered statistically significant using the 
Fisher's exact test (p<0.05).
Results
The survey was available for 5 days (2/2018) and was 
completed by 523 participants. As depicted in figure 1, the 
majority (73%) of participants had non- metastatic disease 
at diagnosis, and 79% had no evidence of disease at time of 
the survey. The most common cancer type among subjects 
was breast, followed by lymphoma and colorectal cancer. 
Among participating patients diagnoses include mela-
noma, sarcoma, cervix, lung, genitourinary, head and neck, 
thyroid, brain cancer and leukaemia. Most participants 
were living with a spouse or family member, 62% consid-
ered themselves secular, and the 63% had high academic 
education. Forty- five per cent considered the network a reli-
able source of medical information. As shown in figure 2A, 
there was no significant difference in patterns of requested 
information according to degree of education and employ-
ment. However, patients with higher academic degree 
were generally more satisfied with the online platform, as 
evident from figure 2B. In contrast, unemployed partici-
pants sought for less medical information and experienced 
better relief of seclusion sense than employed participants. 
There were no differences between cancer survivors and 
patients with active disease in patterns of platform usage, 
nor in domains of interest when analysing data on type 
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Figure 2 Stop cancer users by education and employment (A) Seeking information by education (academic—college/
university; non- academic—high school) and employment status (B) Psychosocial impact—alleviation of seclusion versus 
induction of anxiety.
of treatment received. The social network had an allo-
cated section for ‘patient mentoring’ of newly diagnosed 
members by survivors, which is an interesting addition to 
an online platform.
DIsCussIon
The ubiquitous use of modern technology and social media 
networking has brought this domain into the forefront of 
young patients’ ecosystem for coping with cancer in daily 
life. A burgeoning variety of online resources exists today 
created for and by patients targeting a range of prespec-
ified populations, including forums, blogs, tweet chats, 
message boards and organisational websites. These conven-
ient online platforms offer another form of support in addi-
tion to traditional patient support and self- help groups and 
long- standing hospital- based methods of communication. 
Often healthcare providers are unaware of the significance 
of such networks—as a parallel existence well beyond the 
traditional patient–doctor office encounter. Crucially, these 
platforms are patient driven and can provide key insights 
into methods to improve patient experience. Herein, 
we delineate patient and disease characteristics as well as 
correlations between users and usage, which can be used to 
target specific populations.
Nevertheless, essential processes such as transition to 
survivorship and discussion on disease course intermingle 
and lead to mixed conceptions that cannot be differenti-
ated between cured and active patients. This is evident in 
our study, as there were no significant differences between 
subjects with active disease and those with no evidence of 
disease, in terms of their use of the platform. Additionally, 
the majority of them were free of disease at time of comple-
tion of the survey, yet were still actively using the platform. 
Perhaps more emphasis may be placed within the network 
in aiding survivors in their psychological and physical 
reentry into society and the workforce.
Social media may prove a powerful tool for patients and 
physicians alike, to foster an environment of care- continuity 
and patient- centred medicine, to strengthen the patient–
doctor relationship and connect clinicians with the broad 
community beyond office walls. Importantly, social media is 
also a robust research tool in massive scales.5 6 This unique 
and expanding phenomenon may act as a double- edged 
sword—a fertile core of easily accessible knowledge but also 
as an uncontrolled medical information source. It is our 
role as healthcare providers to join this race and play an 
active role in shaping its medical perspectives.
Our results indicated that the majority of patients using 
the portal had non- metastatic disease, casting doubt on the 
relevance to those with more advanced cancer and issues 
of end of life. Perhaps a portal geared towards metastatic 
patients could better target their needs and identify alter-
native patterns of usage of online social media networks.
While easy and convenient, computer- based commu-
nication cannot replace the traditional classic doctor and 
patient encounter and relationship that we know so well. 
Furthermore, negative, inaccurate health information can 
be distributed online.7 A problem to which we have limited 
solutions. Additionally, privacy issues arise when confronted 
with social media.8
In conclusion, use of social media is an important game- 
changer in the practice of oncology. It is crucial that we, as 
oncologists, join the race and shape its medical perspectives.
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